DDCClass II
Thyroglobulin, Antigen, Antiserum, Control
21 CFR 866.5870 / Immunology
DDC is the FDA product code for Thyroglobulin, Antigen, Antiserum, Control, a class II device type, regulated under 21 CFR 866.5870. As of , FDA records hold 13 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- DDC
- Device name
- Thyroglobulin, Antigen, Antiserum, Control
- Regulation
- 21 CFR 866.5870
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 13
- Ingested recalls
- 1
Clearances, product code DDC
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1978 | 2 |
| 1987 | 1 |
| 1993 | 1 |
| 1994 | 2 |
| 1995 | 1 |
| 1997 | 1 |
| 1999 | 2 |
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
Applicants with the most clearances
Product code DDC| Applicant | Clearances |
|---|---|
| Zeus Scientific LLC | 3 |
| Burroughs Wellcome Co. | 2 |
| Siemens Healthcare Diagnostics Inc. | 1 |
| Biomerica | 1 |
| Cogent Diagnotics, Ltd. | 1 |
| Fujirebio America, Inc. | 1 |
| Inova Diagnostics, Inc. | 1 |
| Miles Laboratories, Inc. | 1 |
| Monobind, Inc. | 1 |
| Quest Intl., Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
